跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
VALOMINDO 160 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA
Approved
STANDARD
VALOMINDO 160 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 12, 2024
Approval ID
444cc565f0214d12
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
444cc565f0214d12
Drug Cima Aemps Name
VALOMINDO 160 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA
Register Number
89696
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Krka Farmaceutica S.L.
Authorization Date
2024-07-12
Dosage Form
COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose
160 mg/1,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Krka D.D. Novo Mesto
Active Ingredients
VALSARTAN
160 mg
INDAPAMIDA
1,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 12, 2024
Approval ID
444cc565f0214d12
Type
Standard
Back to CIMA-AEMPS Approvals
VALOMINDO 160 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA - CIMA-AEMPS Drug Approval Details